This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Medtronic Xomed, Inc.. Active years: 2015-2026.
Company Filing History:
Years Active: 2015-2026
Title: W Jeff Bertrand: Innovator in Fluid Flow Control Devices
Introduction
W Jeff Bertrand is a notable inventor based in Ventura, CA (US), recognized for his contributions to the field of medical technology. He has been awarded 6 patents for his innovative work, particularly in fluid flow control devices and related systems. His inventions have significantly advanced the capabilities of implantable medical devices.
Latest Patents
Bertrand's latest patents include a range of devices and systems that enhance fluid flow control in medical applications. These patents focus on fluid flow control devices, rotors, and magnets that exhibit increased resistance to inadvertent setting changes. Additionally, he has developed implantable physiological shunt systems and accessories designed for improved functionality. His work emphasizes the importance of magnetic coupling in fluid flow control device accessories, ensuring better performance and reliability.
Career Highlights
W Jeff Bertrand is currently associated with Medtronic Xomed, Inc., where he continues to innovate in the medical device sector. His career is marked by a commitment to improving patient outcomes through advanced technology. Bertrand's expertise in fluid dynamics and medical engineering has positioned him as a leader in his field.
Collaborations
Throughout his career, Bertrand has collaborated with talented professionals, including Deep Shah and Lawrence Hampton. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical technologies.
Conclusion
W Jeff Bertrand's contributions to fluid flow control devices and implantable medical systems highlight his role as a significant innovator in the medical technology industry. His patents reflect a dedication to enhancing the functionality and safety of medical devices, ultimately benefiting patients worldwide.